Tag archive for ‘Coronavirus’
Grifols phase 3 Covid-19 trial of hyperimmune globulins fails to meet objective
By businessnewstoday On Saturday, April 3rd, 2021
0 Comments

Grifols phase 3 Covid-19 trial of hyperimmune globulins fails to meet objective

(adsbygoogle = window.adsbygoogle || []).push({}); Spanish pharma company Grifols said that the phase 3 ITAC clinical trial assessing hyperimmune globulins as a treatment for patients hospitalized More...

Tiziana Life Sciences to launch phase 2 trial of Foralumab in Covid-19
By businessnewstoday On Tuesday, March 30th, 2021
0 Comments

Tiziana Life Sciences to launch phase 2 trial of Foralumab in Covid-19

Tiziana Life Sciences said that it plans to launch a phase 2 clinical trial to evaluate the nasal administration of Foralumab in moderate to severe Covid-19 patients. Foralumab is an anti-CD3 human monoclonal antibody More...

Pfizer begins phase 1 study of Covid drug candidate PF-07321332
By businessnewstoday On Wednesday, March 24th, 2021
0 Comments

Pfizer begins phase 1 study of Covid drug candidate PF-07321332

Pfizer said that it has initiated a phase 1 study in the US for assessing the oral antiviral therapeutic PF-07321332 against SARS-CoV-2, the virus that causes Covid-19. The US pharma giant said that it has completed More...

AstraZeneca, US strike deal for up to 500k additional doses of Covid-19 antibody candidate AZD7442
By businessnewstoday On Tuesday, March 16th, 2021
0 Comments

Covid antibody candidate AZD7442 : AstraZeneca, US strike deal for additional doses

AstraZeneca has agreed to supply the US government with up to half a million additional doses of AZD7442, the company’s Covid-19 antibody candidate, for a sum of $205 million. In this connection, AstraZeneca has More...

Cytocom gets FDA nod for phase 2 trial of Covid drug candidate CYTO-205
By businessnewstoday On Tuesday, March 16th, 2021
0 Comments

Cytocom gets FDA nod for phase 2 trial of Covid drug candidate CYTO-205

Cytocom has secured clearance from the US Food and Drug Administration (FDA) to undertake a phase 2 clinical trial of CYTO-205 for the treatment of Covid-19. The company’s investigational new drug (IND) application More...

Russian Covid-19 vaccine Sputnik V
By businessnewstoday On Monday, February 22nd, 2021
0 Comments

Dr. Reddy’s seeks EUA for Russian Covid-19 vaccine Sputnik V from DCGI

Dr. Reddy’s Laboratories said that it has started the process to seek the emergency use authorization (EUA) for the Russian Covid-19 vaccine Sputnik V from the Drugs Controller General of India (DCGI). The Indian More...

By pharmanewsdaily On Friday, February 5th, 2021
0 Comments

Pfizer withdraws application for BNT162b2 Covid-19 vaccine in India

US pharma giant Pfizer has withdrawn its application in India seeking emergency use authorization for its BNT162b2 Covid-19 vaccine. The decision to withdraw the coronavirus vaccine comes following a meeting with More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Friday, February 5th, 2021
0 Comments

Pfizer withdraws application for BNT162b2 Covid-19 vaccine in India

US pharma giant Pfizer has withdrawn its application in India seeking emergency use authorization for its BNT162b2 Covid-19 vaccine. The decision to withdraw the coronavirus vaccine comes following a meeting with More...

By pharmanewsdaily On Saturday, January 23rd, 2021
0 Comments

UAE approves Russia-made Sputnik V Covid-19 vaccine

The Russian Direct Investment Fund (RDIF) said that the Russian Sputnik V Covid-19 vaccine has been authorized for use by the UAE Ministry of Health and Prevention (MOHAP) in the country for providing protection More...

MSCP wraps up $330m sale of majority stake in Hojeij Branded Foods to Lagardere
By pharmanewsdaily On Saturday, January 23rd, 2021
0 Comments

UAE approves Russia-made Sputnik V Covid-19 vaccine

The Russian Direct Investment Fund (RDIF) said that the Russian Sputnik V Covid-19 vaccine has been authorized for use by the UAE Ministry of Health and Prevention (MOHAP) in the country for providing protection More...